Position in JNJ
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$59,640,029
+$311,019 QoQ
Shares Held
234,831
-3.2% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#406
of 4,676 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atria Investments, Inc holds $241,408,936 across 16 Drug Manufacturers - General names. JNJ ranks #1 (24.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
234,831 | $59,640,029 | |
| 2 | LLY |
ELI LILLY & Co
|
34,121 | $40,925,754 | |
| 3 | ABBV |
AbbVie Inc.
|
154,317 | $38,832,329 | |
| 4 | MRK |
Merck & Co., Inc.
|
190,293 | $24,452,650 | |
| 5 | AMGN |
Amgen Inc
|
43,724 | $15,833,334 | |
| 6 | AZN |
Astrazeneca PLC
|
69,989 | $13,271,314 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
76,216 | $9,629,129 | |
| 8 | NVS |
Novartis AG
|
60,245 | $9,441,596 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,640,029 | 234,831 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $59,329,010 | 242,714 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $51,080,433 | 246,825 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $44,881,467 | 242,053 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $36,443,400 | 238,582 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $40,303,431 | 243,026 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $29,829,321 | 206,260 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $32,909,524 | 203,070 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $28,887,647 | 197,644 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $34,863,968 | 220,393 | Shares | Sole | 2024-05-21 | |
| 2023-12-31 | $32,511,324 | 207,422 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $32,208,477 | 206,796 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $34,325,703 | 207,381 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $30,971,945 | 199,819 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $34,835,380 | 197,200 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $31,046,894 | 190,052 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $33,009,582 | 185,959 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $30,058,030 | 169,599 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $28,236,985 | 165,061 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $26,983,581 | 167,081 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $27,576,981 | 167,397 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $23,704,529 | 144,232 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $21,946,798 | 139,451 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $19,032,670 | 127,839 | Shares | Sole | 2020-11-05 | |
| 2020-06-30 | $15,503,191 | 110,241 | Shares | Sole | 2020-09-22 | |
| No filing history on record for this holder in this stock. | ||||||